HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

3-(3-(Hexylthio)-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine

HCID 131460
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
131987-54-7
Standard SMILES
CCCCCCSc1nsnc1C1=CCCN(C)C1
InChIKey
XUHMGFKQBWZWPO-UHFFFAOYSA-N
Molecular formula
C14H23N3S2
Average molar mass
297.5 g/mol
Monoisotopic mass
297.13334009

Overview

Tazomeline is a small molecule drug. Tazomeline has a monoisotopic molecular weight of 297.13 Da.

Names & identifiers

Preferred name
3-(3-(Hexylthio)-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine
IUPAC
3-hexylsulfanyl-4-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)-1,2,5-thiadiazole
English name
Tazomeline
Molecular formula
C14H23N3S2
Molecular weight
297.48

Names & synonyms

(3-Hexylthio)-tztp3-(3-(Hexylthio)-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridineRefChem:187623Tazomeline131987-54-7Tazomeline [INN]3-hexylsulfanyl-4-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)-1,2,5-thiadiazoleQDP6S14W5WLY-287041CHEMBL131819hexylthio-tztpPyridine, 3-(4-(hexylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methyl-
Show more names
Pyridine, 3-[4-(hexylthio)-1,2,5-thiadiazol-3-yl]-1,2,5,6-tetrahydro-1-methyl-
UNII-QDP6S14W5WtazomelinaSCHEMBL195235orb1745176DTXSID80157288BDBM500033555-[4-(hexylsulfanyl)-1,2,5-thiadiazol-3-yl]-1-methyl-1,2,3,6-tetrahydropyridineDA-78230

Database identifiers

CAS
131987-54-7
PubChem CID
131460
DTXSID
DTXSID80157288

Properties

Computed structural propertiesFilling in

XLogP
3.8
Topological polar surface area
82.6 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
5
Rotatable bonds
7
Heavy atoms
19
Formal charge
0
Complexity
296

Physicochemical properties

Boiling point
407.8 · 407.8±45.0 °C(Predicted)
Density
1.15 · 1.15±0.1 g/cm3(Predicted)
pka
7.42 · 7.42±0.40(Predicted)
FDA UNII
6 S14W5W · QDP6S14W5W
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
280 · P280-P305+P351+P338

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H319-H335
Precautionary statements
P280-P305+P351+P338

Chemistry & industry

Applications

UsesAlzheimer’s disease treatment (cholinergic agonist).

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
ChEMBL
CHEMBL131819
UNII
QDP6S14W5W
Nikkaji
J489.349B